{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:31:41Z","timestamp":1767375101142},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.etap.2005.07.003","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T14:08:39Z","timestamp":1123682919000},"page":"135-140","source":"Crossref","is-referenced-by-count":8,"title":["In vitro and animal models of drug-induced blood dyscrasias"],"prefix":"10.1016","volume":"21","author":[{"given":"Julia","family":"Ip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack P.","family":"Uetrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2005.07.003_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000203608","article-title":"Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment","volume":"98","author":"Aizawa","year":"1997","journal-title":"Acta Haematol."},{"key":"10.1016\/j.etap.2005.07.003_bib2","doi-asserted-by":"crossref","first-page":"92P","DOI":"10.1111\/j.2042-7158.1986.tb14321.x","article-title":"Haematological effects of aminoglutethimide in the mouse","volume":"38","author":"Ali","year":"1986","journal-title":"J. Pharm. Pharmcol."},{"key":"10.1016\/j.etap.2005.07.003_bib3","first-page":"2","article-title":"Drug-induced immune thrombocytopenia: an overview of pathogenesis","volume":"36","author":"Aster","year":"1999","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.etap.2005.07.003_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.etap.2005.07.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.1992.tb00086.x","article-title":"The in vitro effect of amodiaquine on bone marrow granulocyte-macrophage progenitor cells from normal subjects","volume":"6","author":"Aymard","year":"1992","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/bmj.291.6500.970-b","article-title":"Aminoglutethimide-induced agranulocytosis in breast cancer","volume":"291","author":"Caldwell","year":"1985","journal-title":"Br. Med. J."},{"key":"10.1016\/j.etap.2005.07.003_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000235138","article-title":"Immunogenicity of amodiaquine in the rat","volume":"91","author":"Clarke","year":"1990","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.etap.2005.07.003_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000235475","article-title":"Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine","volume":"95","author":"Clarke","year":"1991","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.etap.2005.07.003_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.etap.2003.08.003","volume":"15","author":"Coleman","year":"2003","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib10","first-page":"882","article-title":"In vitro effect of clozapine on hemopoietic progenitor cells","volume":"83","author":"Deliliers","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.etap.2005.07.003_bib11","first-page":"814","article-title":"A mechanistic approach to understanding the species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions","volume":"28","author":"Dieckhaus","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0021-9258(18)89636-3","article-title":"The formation of aminopyrine cation radical by peroxidase activity of prostaglandin H synthase and subsequent reactions of the radical","volume":"260","author":"Eling","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.etap.2005.07.003_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/tx034238n","article-title":"Characterization of glutathione conjugates of the remoxipride hydroquinone metabolite NCQ-344 formed in vitro and detection following oxidation by human neutrophils","volume":"17","author":"Erve","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug\u2013protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003495-199753020-00007","article-title":"Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses","volume":"53","author":"Fulton","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.etap.2005.07.003_bib16","first-page":"999","article-title":"A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib17","first-page":"991","article-title":"A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/026119299602400212","article-title":"The use of in vitro systems for evaluating haematotoxicity","volume":"24","author":"Gribaldo","year":"1996","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.etap.2005.07.003_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-483X(98)00110-3","article-title":"Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis","volume":"131","author":"Guest","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.etap.2005.07.003_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","article-title":"Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)","volume":"58","author":"Hedenmalm","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.1934.02750150017005","article-title":"Neutropenia following amidopyrine","volume":"102","author":"Hoffman","year":"1934","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.etap.2005.07.003_bib22","first-page":"1089","article-title":"Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro","volume":"26","author":"Kapetanovic","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.etap.2005.07.003_bib23","first-page":"1476","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2005.07.003_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-2952(88)90733-2","article-title":"Drug\u2013protein conjugates-XIV: mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatoxin in man","volume":"37","author":"Maggs","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib25","first-page":"1463","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man","volume":"275","author":"Maggs","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2005.07.003_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0009-2797(99)00105-2","article-title":"Induction of apoptosis by remoxipride metabolites in HL60 and CD34+\/CD19-human bone marrow progenitor cells: potential relevance to remoxipride-induced aplastic anemia","volume":"121","author":"McGuinness","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.etap.2005.07.003_bib27","first-page":"1003","article-title":"Aminoglutethimide-induced hematologic toxicity: worldwide experience","volume":"69","author":"Messeih","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.etap.2005.07.003_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000204146","article-title":"Agranulocytosis due to the occurrence of leukocyte-agglutinins","volume":"8","author":"Moeschlin","year":"1952","journal-title":"Acta Haematol."},{"key":"10.1016\/j.etap.2005.07.003_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1010958121396","article-title":"In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs","volume":"17","author":"Negro","year":"2001","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00002018-199309060-00009","article-title":"Relevance of in vitro studies of drug-induced agranulocytosis. Report of 14 cases","volume":"9","author":"Parent-Massin","year":"1993","journal-title":"Drug Saf."},{"key":"10.1016\/j.etap.2005.07.003_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/tx980058f","article-title":"Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective","volume":"11","author":"Park","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/toxsci\/kfg188","article-title":"Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics","volume":"75","author":"Pessina","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.etap.2005.07.003_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-199631030-00005","article-title":"Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism","volume":"31","author":"Pirmohamed","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.etap.2005.07.003_bib34","first-page":"254","article-title":"Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis","volume":"119","author":"Pisciotta","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.etap.2005.07.003_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0006-3223(93)90196-K","article-title":"Effects of clozapine on hematopoiesis and the cytokine system","volume":"34","author":"Sperner-Unterweger","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.etap.2005.07.003_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/tx9601566","article-title":"Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate","volume":"9","author":"Thompson","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03602539208996297","article-title":"The role of leukocyte-generated metabolites in the pathogenesis of idiosyncratic drug reactions","volume":"24","author":"Uetrecht","year":"1992","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.etap.2005.07.003_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx980249i","article-title":"New concepts in immunology relevant to idiosyncratic drug reactions: the \u201cdanger hypothesis\u201d and innate immune system","volume":"12","author":"Uetrecht","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1389200003339081","article-title":"Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?","volume":"1","author":"Uetrecht","year":"2000","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.etap.2005.07.003_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/tx00044a007","article-title":"Oxidation of aminopyrine by hypochlorite to a reactive dication: possible implications for aminopyrine-induced agranulocytosis","volume":"8","author":"Uetrecht","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2005.07.003_bib41","first-page":"865","article-title":"Metabolism of vesnarinone by activated neutrophils; implications for vesnarinone-induced agranulocytosis","volume":"270","author":"Uetrecht","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2005.07.003_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmj.291.6488.105-a","article-title":"Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer","volume":"291","author":"Vincent","year":"1985","journal-title":"Br. Med. J."},{"key":"10.1016\/j.etap.2005.07.003_bib43","first-page":"1375","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis","volume":"283","author":"Williams","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2005.07.003_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.58.1.207","article-title":"Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine","volume":"58","author":"Williams","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.etap.2005.07.003_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2125.1990.tb03667.x","article-title":"The toxicity of amodiaquine and its principal metabolites towards mononuclear leukocytes and granulocyte\/monocyte colony forming units","volume":"29","author":"Winstanley","year":"1990","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138266890500116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138266890500116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T04:24:46Z","timestamp":1626323086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138266890500116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S138266890500116X"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2005.07.003","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}